Sercan Ergün
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- RNA Interference and Gene Delivery
- Inflammasome and immune disorders
Papers in
-
- Circular RNAs in diseases 8
- Epigenetics and DNA Methylation 3
- Ubiquitin and proteasome pathways 2
- RNA Interference and Gene Delivery 2
- Renal and related cancers 2
-
- MicroRNA in disease regulation 13
- Cancer-related molecular mechanisms research 6
- Co-authors
- Serdar Öztuzcu (16 shared papers)Nina Petrović (7 shared papers)Esma R. Isenović (1 shared paper)Ebru Temiz (6 shared papers)Yusuf Ziya İğci (5 shared papers)Ecir Ali Çakmak (5 shared papers)Ahmet Arslan (4 shared papers)Sezgin Güneş (8 shared papers)
- Journals
- Molecular Biology Reports (7 papers)Molecular Diagnosis & Therapy (3 papers)Anti-Cancer Agents in Medicinal Chemistry (2 papers)Gene (2 papers)Tumor Biology (2 papers)
- Partner nations
- TürkiyeSerbiaUnited States
In The Last Decade
Sercan Ergün
37 papers receiving 653 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 349
- Molecular Biology 364
- Hematology 48
- Nephrology 18
- Genetics 22
Countries citing papers authored by Sercan Ergün
This map shows the geographic impact of Sercan Ergün's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sercan Ergün with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sercan Ergün more than expected).
Fields of papers citing papers by Sercan Ergün
This network shows the impact of papers produced by Sercan Ergün. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sercan Ergün. The network helps show where Sercan Ergün may publish in the future.
Co-authors
The 25 scholars most cited alongside Sercan Ergün, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 156 | |
| 2 | 2014 | 52 | |
| 3 | 2018 | 49 | |
| 4 | 2014 | 44 | |
| 5 | 2017 | 43 | |
| 6 | 2014 | 31 | |
| 7 | 2015 | 21 | |
| 8 | 2018 | 20 | |
| 9 | 2014 | 20 | |
| 10 | 2014 | 20 | |
| 11 | 2014 | 18 | |
| 12 | 2014 | 18 | |
| 13 | 2014 | 14 | |
| 14 | 2019 | 13 | |
| 15 | 2015 | 13 | |
| 16 | 2021 | 13 | |
| 17 | 2024 | 12 | |
| 18 | 2015 | 12 | |
| 19 | 2016 | 9 | |
| 20 | 2016 | 9 |
About Sercan Ergün
Sercan Ergün is a scholar working on Molecular Biology, Cancer Research, Oncology, Hematology and Nephrology, having authored 44 papers that have together received 659 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Circular RNAs in diseases (8 papers), Cancer-related molecular mechanisms research (6 papers), Epigenetics and DNA Methylation (3 papers), Ubiquitin and proteasome pathways (2 papers), Renal cell carcinoma treatment (2 papers), RNA Interference and Gene Delivery (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Cancer Research (349 citations), Molecular Biology (364 citations), Hematology (48 citations), Nephrology (18 citations) and Genetics (22 citations). Sercan Ergün has collaborated with scholars based in Türkiye, Serbia and United States. Frequent co-authors include Serdar Öztuzcu, Nina Petrović, Esma R. Isenović, Ebru Temiz, Yusuf Ziya İğci, Ecir Ali Çakmak, Ahmet Arslan, Sezgin Güneş, Enes Coşkun and Ali Bay. Their work appears in journals such as Molecular Biology Reports, Molecular Diagnosis & Therapy, Anti-Cancer Agents in Medicinal Chemistry, Gene and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.